Pharma & Life Sciences Global (1001+ employees)

Regulatory Affairs Specialist at Global

High Conscientiousness and Openness to manage registration dossiers, engage regulatory agencies, and anticipate regulatory changes across LATAM.

Global pharma means registrations in dozens of markets with different requirements

Multi-site clinical trials are extreme international coordination projects

Pricing and access pressures vary drastically between countries

Generic profile Startup (1-50 employees) SMB (51-200 employees) Enterprise (201-1000 employees)

Ideal OCEAN+ Profile

Ideal range

Openness

57 72

At global corporations (1001+ employees), ability to interpret complex regulations, identify precedents, and design registration strategies in response to regulatory changes across LATAM

Conscientiousness

92 100

At global corporations (1001+ employees), absolute precision in preparing dossiers, tracking regulatory deadlines, and keeping registration documentation current

Extraversion

40 57

At global corporations (1001+ employees), ability to engage with regulatory authorities and represent the company's position before agencies such as COFEPRIS, ANMAT, or ANVISA

Agreeableness

70 85

At global corporations (1001+ employees), collaboration with quality, medical, legal, and marketing teams to align registration strategies with business needs

Emotional Stability

63 77

At global corporations (1001+ employees), managing stress under immovable regulatory deadlines, agency queries, and the risk of product unavailability

Structure & Rhythm

97 100

At global corporations (1001+ employees), regulatory Affairs operates on defined submission procedures, ICH/FDA/EMA guidelines, and agency response timelines; any deviation from the submission process can result in rejection, delay, or regulatory sanction

Strengths and Red Flags

Strengths

Preparing and managing registration dossiers with a high first-round approval rate
Interpreting local and international regulations (ICH, CTD, eCTD)
Registering and commercializing pharmaceutical products across multiple regulatory markets
Managing multi-site, multi-country clinical trials under ICH-GCP standards

Red Flags

Superficial dossier review that generates avoidable agency queries
Regulatory knowledge gaps that lead to strategies based on outdated rules
Underestimates the variability of regulatory requirements across markets
Centralized registration management that ignores local particularities

Interview Questions

What was the most complex registration dossier you prepared? What queries did you get from the agency, and how did you respond to them?

Evaluates: Conscientiousness and handling complex regulatory interactions

Describe how you monitor regulatory changes in the countries in your portfolio. Give me an example of a recent change you anticipated and how it affected the business.

Evaluates: Openness and proactive regulatory intelligence

How did you manage a multi-site, multi-country clinical trial?

Evaluates: International coordination and multi-regulatory compliance

How did you navigate pricing and access differences between markets?

Evaluates: Strategic thinking and sensitivity to local health dynamics